Angeles
Therapeutics

Angeles TherapeuticsAngeles TherapeuticsAngeles Therapeutics
  • Home
  • About
  • Scientific Founder
  • Our Science
    • Platforms
    • Intellectual Property
    • Pipeline
  • News
    • Publications
    • News and Media
  • Contact Us
  • More
    • Home
    • About
    • Scientific Founder
    • Our Science
      • Platforms
      • Intellectual Property
      • Pipeline
    • News
      • Publications
      • News and Media
    • Contact Us

Angeles
Therapeutics

Angeles TherapeuticsAngeles TherapeuticsAngeles Therapeutics
  • Home
  • About
  • Scientific Founder
  • Our Science
    • Platforms
    • Intellectual Property
    • Pipeline
  • News
    • Publications
    • News and Media
  • Contact Us

NEWS AND MEDIA

El Matador Beach, Malibu, California

News Media and Press Releases


  1. Angeles Therapeutics announces the award of a patent in China covering a novel approach to providing co-stimulation for adoptive cell therapies and use of Src/Lck inhibitors, such as Dasatinib and Ponatinib, in combination with CAR cells. January 27, 2023
  2. Department of Defense (DoD) awards a Peer Reviewed Cancer Research Program Idea Award to the lab of Preet M. Chaudhary, MD, PhD. to develop a next generation CAR (SIR) for the treatment of Prostate Cancer. Jan 23, 2023
  3. Angeles Therapeutics announces the award of a US Patent covering a novel method to isolate stem like T and NK cells for adoptive cell therapies. January 21, 2023
  4. Angeles Therapeutics announces the award of a US Patent (US 11307205B2) covering the Matador non-radioactive cytotoxicity assays. May 28, 2022
  5. Department of Defense (DoD) recommends for funding a Peer Reviewed Cancer Research Program Idea Award application of Preet M. Chaudhary, MD, PhD. to develop a next generation bispecific CAR (SIR) for the treatment of Lymphoma. May 14, 2022
  6. Department of Defense (DoD) awards a Kidney Cancer Research Program Concept Award to the laboratory of Preet M. Chaudhary, MD, PhD. to develop a next generation CAR for the treatment of Kidney Cancer. May 5, 2022
  7. California Institute for Regenerative Medicine (CIRM) awards $5.8M to the laboratory of Dr. Preet Chaudhary to develop Synthetic Immune Receptor (SIR),  a next generation Chimeric antigen receptor, for the treatment of prostate cancer.  April 19, 2022
  8.  Dr. Preet Chaudhary awarded  CIRM grant to develop iPSC derived NK CAR against COVID-19. June 26, 2020
  9. Illuminating New Biomedical Discoveries: Bioluminescent, biofluorescent species glow with promise. June 7, 2019.
  10. Bioluminescent, Biofluorescent Species Light the Way to New Biomedical Discoveries. Dec. 11, 2019.
  11. Deep sea creatures provide a guiding light in the quest to develop cancer therapies. Science Daily. January 9, 2018
  12. The Long Evolution Of CAR-T Assays.  Diagnostic World. July 22, 2019.
  13. Bioluminescent deep-sea creatures illuminate effectiveness of new cancer therapies. Feb 15, 2019.


Find out more

Videos

 

  •  Dr. Chaudhary on History of CAR T-Cell Therapy  Jan 11, 2017 
  •  Dr. Chaudhary on Remaining Challenges With CAR T-Cell Therapy. Jan 25, 2017.
  • Dr. Chaudhary on Short-Term and Long-Term Future of CAR T Cells

Angeles Therapeutics

preet.chaudhary@angelestherapeutics.com

Copyright © 2021 Angeles Therapeutics, Inc - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept